Animal models of inflammatory spinal and sacroiliac joint diseases

Rheumatic Disease Clinics of North America

Volumn 29, Issue 3, 2003, Pages 631-645

  Zhang, Yiping ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AG1 ANTIGEN; AGGRECAN; ANTIGEN; CARTILAGE MATRIX PROTEIN; COLLAGEN TYPE 11; COLLAGEN TYPE 2; COLLAGEN TYPE 9; EPITOPE; GP39 ANTIGEN; HLA B27 ANTIGEN; LP ANTIGEN; MATRILIN 1; PROTEOGLYCAN; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VERSICAN; VG1 ANTIGEN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKYLOSING SPONDYLITIS; BROWN SYNDROME; CARTILAGE; CARTILAGE CELL; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; ENTHESITIS; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOGENESIS; INFLAMMATION; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; POLYARTHRITIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; RHEUMATIC DISEASE; SACROILIITIS; SEQUENCE HOMOLOGY; SPONDYLITIS; SUPERIOR OBLIQUE MUSCLE; TENDON; TRANSGENIC ANIMAL; TRANSGENIC MOUSE;

EID: 0041520672     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(03)00049-8     Document Type: Review

References (94)

1. Khan MA. Ankylosing spondylitis: clinical aspects. In: Calin A, Taurog JD, editors. Oxford: Oxford University Press; 1998. p. 27-40.
2. Braun J, Bollow M, Sieper J. Radiologic diagnosis and pathology of the spondyloarthropathies. Rheum Dis Clin N Am 1998;24:697-735.
3. Burgos-Vargas R, Granados J. Ankylosing spondylitis and related diseases in the Mexican Mesitizo. Spine 1990;4:665-78.
4. Claudepierre P, Gueguen A, Ladjouze A, et al. Predictive factors of severity of spondyloarthropathy in North Africa. Br J Rheumatol 1995;34:1139-45.
5. Arnett FC. Histocompatibility typing in the rheumatic diseases. Diagnostic and prognostic implications. Rheum Dis Clin N Am 1994;20:371-90.
6. Khan MA. A worldwide overview: the epidemiology of HLA-B27 and associated spondyloarthritides. Oxford: Oxford University Press; 1998.
7. Dougados M, Vanderlinden S, Juhlin R, et al. The European-Spondylarthropathy-Study-Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
8. McGonagle D, Khan MA, Marzo-Ortega H, et al. Enthesitis in spondyloarthropathy. Curr Opin Rheumatol 1999;11:244-50.
9. Banares A, Hernandez-Garcia C, Fernandez-Gutierrez B, et al. Eye involvement in the spondyloarthropathies. Rheum Dis Clin N Am 1998;24:771-84, ix.
10. Gladman DD. Clinical aspects of the spondyloarthropathies. Am J Med Sci 1998;316:234-8.
11. Olivieri I, Barozzi L, Padula A, et al. Clinical manifestations of seronegative spondylarthropathies. Eur J Radiol 1998;27:S3-6.
12. Satko SG, Iskandar SS, Appel RG. IgA nephropathy and Reiter's syndrome. Report of two cases and review of the literature. Nephron 2000;84:177-82.
13. Eulderink F. Pathology of ankylosing spondylitis. Spine 1990;4:507-28.
14. Braun J, Bollow M, Neure L, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995;38:499-505.
15. Shichikawa K, Tsujimoto M, Nishioka J, Nishibayashi Y, Matsumoto K. Histopathology of early sacroiliitis and enthesitis in ankylosing spondylitis. In: Ziff M, Cohen SB, editors. Advances in inflammation research, Volume 9. New York: Raven Press; 1985.
16. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunol 1997;53:1-11.
17. Fiorillo MT, Maragno M, Butler R, et al. CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J Clin Invest 2000;106:47-53.
18. Lopez de Castro JA. The pathogenetic role of HLA-B27 in chronic arthritis. Curr Opin Immunol 1998;10:59-66.
19. Hammer RE, Maika SD, Richardson JA, et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990;63:1099-112.
20. Taurog JD, Maika SD, Satumtira N, et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 1999;169:209-23. i
21. Poole AR, Kojima T, Yasuda T, et al. Composition and structure of articular cartilage - a template for tissue repair. Clinical Orthopaedics and Related Research 2001;391:S26-33.
22. Poole AR. Immunochemical markers of joint inflammation, skeletal damage and repair - where are we now. Ann Rheum Dis 1994;53:3-5.
23. Francois RJ. Ligament insertions into the human lumbar vertebral body. Acta Anat [Basel] 1975;91:467-80.
24. Nakamura T, Hashimoto N, Maeda Y, et al. Degeneration and ossification of the yellow ligament in unstable spine. J Spinal Disord 1990;3:288-92.
25. Scapinelli R. Morphological and functional changes of the lumbar spinous processes in the elderly. Surg Radiol Anat 1989;11:129-33.
26. Sztrolovics R, Grover J, Cs-Szabo G, et al. The characterization of versican and its message human articular cartilage and intervertebral disc. J Orthop Res 2002;20:257-66.
27. Melrose J, Ghosh P, Taylor TK. A comparative analysis of the differential spatial and temporal distributions of the large (aggrecan, versican) and small (decorin, biglycan, fibromodulin) proteoglycans of the intervertebral disc. Anat 2001;198:3-15.
28. Melrose J, Smith S, Ghosh P. Differential expression of proteoglycan epitopes by ovine intervertebral disc cells. J Anat 2000;197(Pt 2):189-98.
29. Hayes AJ, Benjamin M, Ralphs JR. Extracellular matrix in development of the intervertebral disc. Matrix Biol 2001;20:107-21.
30. Ball J. Enthesopathy ofrheumatoid and ankylosing spondylitis. Ann Rheum Dis 1971;30:213-23.
31. Francois RJ, Gardner DL, Degrave EJ, et al. Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis. Arthritis Rheum 2000;43:2011-24.
32. Brandt J, Bollow M, Haberle J, et al. Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy. Rheumatology [Oxford] 1999;38:831-6.
33. McGonagle D, Gibbon W, Emery P. Classification of inflammatory arthritis by enthesitis. Lancet 1998;352:1137-40. i
34. Kampen WU, Tillmann B. Age-related changes in the articular cartilage of human sacroiliac joint. Anat Embryol [Berl] 1998;198:505-13.
35. Braun J, Khan MA, Sieper J. Enthesitis and ankylosis in spondyloarthropathy: what is the target of the immune response? Ann Rheum Dis 2000;59:985-94.
36. Benjamin M, McGonagle D. The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 2001;199:503-26.
37. Waggett AD, Ralphs JR, Kwan AP, et al. Characterization of collagens and proteoglycans at the insertion of the human Achilles tendon. Matrix Biol 1998;16:457-70.
38. Bode-Lesniewska B, Dours-Zimmermann MT, Odermatt BF, et al. Distribution of the large aggregating proteoglycan versican in adult human tissues. J Histochem Cytochem 1996;44:303-12.
39. Braun J, Bollow M, Eggens U, et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 1994;37:1039-45.
40. Gao J, Messner K, Ralphs JR, et al. An immunohistochemical study of enthesis development in the medial collateral ligament of the rat knee joint. Anat Embryol [Berl] 1996;194:399-406.
41. Secundini R, Scheines EJ, Gusis SE, et al. Clinico-radiological correlation of enthesitis in seronegative spondyloarthropathies (SNSA). Clin Rheumatol 1997;16:129-32.
42. Crew MD, Effros RB, Walford RL, et al. Transgenic mice expressing a truncated Peromyscus leucopus TNF-alpha gene manifest an arthritis resembling ankylosing spondylitis. J Interferon Cytokine Res 1998;18:219-25.
43. MarkerHermann E, Fassbender HG, Kessler S, et al. Transgenic mice with an epidermal over-expression of bone morphogenic protein-6 (BMP-6) present with psoriatic skin lesions and osteoarthropathy. Arthritis Rheum 1997;40:S1382.
44. Sweet H, Green M. Progressive ankylosis, a new skeletal mutation in the mouse. Heredity 1981;72:87-93.
45. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000;289:265-70.
46. Hakim FT, Cranley R, Brown KS, et al. Hereditary joint disorder in progressive ankylosis (ank/ ank) mice. I. Association of calcium hydroxyapatite deposition with inflammatory arthropathy. Arthritis Rheum 1984;27:1411-20.
47. Krug HE, Mahowald ML, Clark C. Progressive ankylosis (ank/ank) in mice: an animal model of spondyloarthropathy. III. Proliferative spleen cell response to T cell mitogens. Clin Exp Immunol 1989;78:97-101.
48. Sampson HW. Spondyloarthropathy in progressive ankylosis (ank/ank) mice: morphological features. Spine 1988;13:645-9.
49. Sampson HW, Davis RW, Dufner DC. Spondyloarthropathy in progressive ankylosis mice: ultrastructural features of the intervertebral disk. Acta Anat [Basel] 1991;141:36-41.
50. Krug HE, Wietgrefe MM, Ytterberg SR, et al. Murine progressive ankylosis is not immunologically mediated. J Rheumatol 1997;24:115-22.
51. Taurog JD, Maika SD, Simmons WA, et al. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 1993;150:4168-78.
52. Kriegsmann J, Franklin BN, Gay RE, et al. [Fusion of vertebrae and the sacroiliac joint by cartilaginous tissue in HLA-B27 transgenic rats]. Verh Dtsch Ges Pathol 1996;80:334.
53. Breban M, Fernandez-Sueiro JL, Richardson JA, et al. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 1996;156:794-803.
54. Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 1996;98:945-53.
55. Weinreich S, Eulderink F, Capkova J, et al. HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Hum Immunol 1995;42:103-15.
56. Khare SD, Hansen J, Luthra HS, et al. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m. J Clin Invest 1996;98:2746-55.
57. Eulderink F, Ivanyi P, Weinreich S. Histopathology of murine ankylosing enthesopathy. Pathol Res Pract 1998;194:797-803.
58. Wolfman NM, Hattersley G, Cox K, et al. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin Invest 1997;100:321-30.
59. Hattersley G, Cox K, Soslowsky L, et al. Bone morphogenetic proteins 2 and 12 alter the attachment of tendonto bone in a rat model: a histological and biomechanical investigation. Transactions of the Orthopaedic Research Society 1988;23:96.
60. Carlsen S, Hansson AS, Olsson H, et al. Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp Immunol 1998;114:477-84.
61. Smith RK, Heinegard D. Cartilage oligomeric matrix protein (COMP) levels in digital sheath synovial fluid and serum with tendon injury. Equine Vet J 2000;32:52-8.
62. Mikecz K, Glant TT, Poole AR. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 1987;30:306-18.
63. Glant TT, Mikecz K, Arzoumanian A, et al. Proteoglycan- induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum 1987;30:201-12.
64. Leroux JY, Guerassimov A, Cartman A, et al. Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo. J Clin Invest 1996;97:621-32.
65. Shi S, Ciurli C, Cartman A, Pidoux I, Poole AR, Zhang Y. Experimental immunity in the G1 domain of the proteoglycan versican induces spondylitis and sacroilitis, of a kind seen in human spondyloarthropathies. Arthritis Rheumatism 2003; in press.
66. Zhang YP, Guerassimov A, Leroux JY, et al. Arthritis induced by proteoglycan aggrecan G1 domain in BALB/c mice. Evidence for T cell involvement and the immunosuppressive influence of keratan sulfate on recognition of T and B cell epitopes. J Clin Invest 1998;101:1678-86.
67. Li NL, Zhang DQ, Zhou KY, et al. Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patients. Cell Res 2000;10:39-49.
68. Mikecz K, Glant TT, Baron M, et al. Isolation of proteoglycan-specific T lymphocytes from patients with ankylosing spondylitis. Cell Immunol 1988;112:55-63.
69. Poole AR. The histopathology of ankylosing spondylitis: are there unifying hypotheses? Am J Med Sci 1998;316:228-33.
70. Guerassimov A, Zhang Y, Banerjee S et al. Autoimmunity to cartilage link protein in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 1998;25:1480-4.
71. Zhang Y, Guerassimov A, Leroux JY, et al. Induction of arthritis in BALB/c mice by cartilage link protein: involvement of distinct regions recognized by T and B lymphocytes. Am J Pathol 1998;153:1283-91.
72. Giant TT, Bardos T, Vermes C, et al. Variations in susceptibility to proteoglycan-induced arthritis, and spondylitis among C3H substrains of mice: evidence of genetically acquired resistance to autoimmune disease. Arthritis Rheum 2001;44:682-92.
73. Guerassimov A, Zhang YP, Banerjee S, et al. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. Arthritis Rheum 1998;41:1019-25.
74. Li LN, Zhang DQ, Zhou KY, Cartman A, Leroux JY, Poole AR, et al. Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patients. Cell Research 2000;10:39-49.
75. Shi S, Keystone EC, Fitzcharles MA, et al. Autoreactive T cells specific to aggrecan G1 domain are present at a high frequency in the synovial fluid compartment of RA patients. Arthritis Rheum 2000;43:S157.
76. Ciurli C, Leroux JY, Cartman A, et al. Induction of human arthritic pathology in SCID mice via transfer of autore-active T cell line specific to human aggrecan G1 protein. Arthritis Rheum 1999;42:S119.
77. Zimmermann DR, Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J 1989;8:2975-81.
78. Lebaron RG, Zimmermann DR, Ruoslahti E. Hyaluronate binding-properties of versican. J Biol Chem 1992;267:10003-10.
79. Doege KJ, Sasaki M, Kimura T, et al. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. J Biol Chem 1991;266:894-902.
80. Osborne-Lawrence SL, Sinclair AK, Hicks RC, et al. Complete amino acid sequence of human cartilage link protein (CRTL1) deduced from cDNA clones and chromosomal assignment of the gene. Genomics 1990;8:562-7.
81. Francois RJ, Braun J, Khan MA. Entheses and enthesitis: a histopathologic review and relevance to spondyloarthritides. Curr Opin Rheumatol 2001;13:255-64.
82. Dihlmann W, Lindenfelser R, Selberg W. [Histomorphology of the sacroiliac joint in ankylosing spondylitis and relevance to treatment (author's translation)]. Dtsch Med Wochenschr 1977;102:129-32.
83. Zhang Y, Cao L, Kiani C, et al. Promotion of chondrocyte proliferation by versican mediated by G1 domain and EGF-like motifs. J Cell Biochem 1999;73:445-57.
84. Singer II, Kawka DW, Bayne EK, et al. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J Clin Invest 1995;95:2178-86.
85. van Meurs J, van Lent P, Stoop R, et al. Cleavage of aggrecan at the ASN(341)-PHE342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis - a pivotal role for stromelysin 1 in matrix metalloproteinase activity. Arthritis Rheum 1999;42:2074-84.
86. Poole AR, Pidoux I, Reiner A, et al. Mammalian eyes and associated tissues contain molecules that are immunologically related to cartilage proteoglycan and link protein. J Cell Biol 1982;93:910-20.
87. Gardell S, Baker J, Caterson B, et al. Link protein and a hyaluronic acid-binding region as components of aorta proteoglycan. Biochem Biophys Res Commun 1980;95:1823-31.
88. Milz S, Regner F, Putz R, et al. Expression of a wide range of extracellular matrix molecules in the tendon and trochlea of the human superior oblique muscle. Invest Ophthalmol Vis Sci 2002;43:1330-4.
89. Walcz E, Deak F, Erhardt P, et al. Complete coding sequence, deduced primary structure, chromosomal localization, and structural analysis of murine aggrecan. Genomics 1994;22:364-71.
90. Zhang YP, Guerassimov A, Leroux JY, et al. Induction of arthritis in BALB/c mice by cartilage link protein - Involvement of distinct regions recognized by T and B lymphocytes. Am J Pathol 1998;153:1283-91.
91. Leroux JY, Guerassimov A, Cartman A, et al. Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo. J Clin Invest 1996;97:621-32.
92. Stuart JM, Townes AS, Kang AH. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest 1982;69:673-83.
93. Boissier MC, Chiocchia G, Ronziere MC, et al. Arthritogenicity of minor cartilage collagens (types IX and XI) in mice. Arthritis Rheum 1990;33:1-8.
94. Verheijden GF, Rijnders AW, Bos E, et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 1997;40:1115-25.